BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Eisai Company, Ltd. 

4-6-10 Koishikawa, Bunkyo-ku

Tokyo    112-8088  Japan
Phone: 81-3-3817-3700 Fax: n/a


SEARCH JOBS




 Key Statistics


Email: webmaster@eisai.co.jp
Ownership:

Web Site: Eisai Company, Ltd.
Employees: 7,043
Symbol: ESALY.PK
 









 Company News
Eisai Company, Ltd. (ESALY.PK) Sues The FDA To Regain "Lost" Marketing Time For Its Drugs 8/18/2014 6:14:23 AM
Eisai Company, Ltd. (ESALY.PK) Submits First Marketing Authorization Application For Anticancer Agent Lenvatinib In Japan 7/18/2014 7:46:23 AM
Lexicon Pharmaceuticals, Inc. (LXRX) Brings In Ex-Eisai Company, Ltd. (ESALY.PK) Exec As New President And CEO 7/8/2014 6:22:48 AM
Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million 7/7/2014 6:41:06 AM
Boston Strategics Corporation Announces Licensing Deal With Eisai Company, Ltd. (ESALY.PK) 7/1/2014 11:17:42 AM
Eisai Company, Ltd. (ESALY.PK)'s R&D Subsidiary Kan Research Institute Commences Full-Scale Operation at New Facility 5/30/2014 9:47:09 AM
Eisai Company, Ltd. (ESALY.PK) Receives Positive Opinion From European Medicines Agency's CHMP On Expanding 5/30/2014 9:44:05 AM
Eisai Company, Ltd. (ESALY.PK) Enters Collaboration With Liverpool School Of Tropical Medicine And University of Liverpool To Discover Novel Anti-Wolbachia Targeted Anti-Filarial Drugs 3/20/2014 10:12:39 AM
Biogen Idec, Inc. (Massachusetts) (BIIB) Buys Rights To Eisai Company, Ltd. (ESALY.PK) Alzheimer's Drugs, Amount Undisclosed 3/5/2014 6:32:22 AM
Eisai Company, Ltd. (ESALY.PK)'s Lenvatinib Phase 3 Trial Meets Primary Endpoint Of Progression Free Survival In Radioiodine-Refractory Differentiated Thyroid Cancer 2/3/2014 6:46:01 AM
12345678910...